Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression

Metformin Reverses Progestin Resistance in Endometrial Cancer Cells by Downregulating GloI Expression

(2011) Zhenbo Zhang et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer

(2010) T. Jiang et al.   CANCER RESEARCH

Combined Chemotherapy Regimen of Carboplatin and Paclitaxel as Adjuvant Treatment for Papillary Serous and Clear Cell Endometrial Cancer

(2010) Gil Shechter-Maor et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Conservative Treatment With Progestin and Pregnancy Outcomes in Endometrial Cancer

(2010) Ho-Suap Hahn et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Reverse of Progestin-Resistant Atypical Endometrial Hyperplasia by Metformin and Oral Contraceptives

(2010) Zong-Qi Shen et al.   OBSTETRICS AND GYNECOLOGY

Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer

(2009) Zhenbo Zhang et al.   CANCER LETTERS

Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission

(2009) H. A. Hirsch et al.   CANCER RESEARCH

Resistance to chemotherapy and hormone therapy in endometrial cancer

(2009) Parvesh Chaudhry et al.   ENDOCRINE-RELATED CANCER

A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer

(2009) O. Zivanovic et al.   GYNECOLOGIC ONCOLOGY

Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy

(2009) Leigh A. Cantrell et al.   GYNECOLOGIC ONCOLOGY

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

(2009) Sao Jiralerspong et al.   JOURNAL OF CLINICAL ONCOLOGY